Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS

Clinical trial NCT01141725 · COMPLETED

Trial details

NCT number: NCT01141725
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)de Novo Myelodysplastic Syndromes Myelodysplastic Syndrome With Isolated Del(5q)Untreated Adult Acute Myeloid Leukemia

Start date: 2010-09-01
Primary completion: 2012-11-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.